Tildrakizumab
Generic name: Tildrakizumab
Brand names: Ilumya
Dosage form: subcutaneous solution (100 mg/mL)
Drug class:
Interleukin inhibitors
Usage of Tildrakizumab
Tildrakizumab reduces the effects of a substance in the body that can cause inflammation.
Tildrakizumab is used to treat moderate to severe psoriasis in adults.
Tildrakizumab may also be used for purposes not listed in this medication guide.
Tildrakizumab side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
You may get infections more easily, even serious or fatal infections. Call your doctor right away if you have signs of infection such as:
Common side effects of tildrakizumab may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Tildrakizumab
You should not be treated with tildrakizumab if you are allergic to it.
Tell your doctor if you have a chronic infection, or if you are scheduled to receive any vaccine.
Tell your doctor if you have ever had tuberculosis or if anyone in your household has tuberculosis.
It is not known whether tildrakizumab will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
It may not be safe to breast-feed while using this medicine. Ask your doctor about any risk.
Tildrakizumab is not approved for use by anyone younger than 18 years old.
Relate drugs
- Actemra
- Actemra ACTPen
- Adbry
- Arcalyst
- Cosentyx
- Basiliximab
- Benralizumab
- Brodalumab
- Canakinumab
- Cinqair
- Daclizumab
- Dupilumab
- Dupixent
- Dupixent Pre-filled Pen
- Dupixent Pre-filled Syringe
- Enspryng
- Fasenra
- Fasenra Pen
- Fasenra Prefilled Syringe
- Guselkumab
- Ilaris
- Ilumya
- Ixekizumab
- Mepolizumab
- Nucala
- Reslizumab
- Rilonacept
- Risankizumab
- Risankizumab-rzaa
- Satralizumab
- Satralizumab-mwge
- secukinumab
- Siliq
- Siltuximab
- Simulect
- Skyrizi
- Skyrizi Pen
- Spesolimab
- Spesolimab-sbzo
- Spevigo
- Stelara
- Sylvant
- Taltz
- Tildrakizumab
- Tildrakizumab-asmn
- Tocilizumab
- Tralokinumab
- Tralokinumab-ldrm
- Tremfya
- Ustekinumab
- Zinbryta
How to use Tildrakizumab
Usual Adult Dose for Plaque Psoriasis:
100 mg suBCutaneously at Weeks 0 and 4, and every 12 weeks thereafterComments:-Evaluate patients for tuberculosis (TB) infection prior to initiating therapy.Use: For adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy
Warnings
Tildrakizumab affects your immune system. You may get infections more easily. Call your doctor if you have a fever, chills, aches, cough, shortness of breath, skin sores, diarrhea, weight loss, or burning when you urinate.
What other drugs will affect Tildrakizumab
Other drugs may affect tildrakizumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions